Hyaluronidases in Cancer Biology

Hyaluronan in Cancer Biology

Volumn , Issue , 2008, Pages 207-220

  Stern, Robert ^a  

^a AL QUDS UNIVERSITY   (Palestine)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864314287     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012374178-3.10012-2     Document Type: Chapter

References (64)

1. Baumgartner G., Gomar-Höss C., Sakr L., Ulsperger E., Wogritsch C. The impact of extracellular matrix on the chemoresistance of solid tumors - experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy. Cancer Lett 1998, 131:85-99.
2. Beckenlehner K., Bannke S., Spruss T., et al. Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo. J Cancer Res Clin Oncol 1992, 118:591-596.
3. Beech D.J., Madan A.K., Deng N. Expression of PH-20 in normal and neoplastic breast tissue. J Surg Res 2002, 103:203-207.
4. Bourguignon L.Y., Singleton P.A., Diedrich F., Stern R., Gilad E. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem 2004, 279:26991-27007.
5. Chang N.S. Transforming growth factor-beta protection of cancer cells against tumor necrosis factor cytotoxicity is counteracted by hyaluronidase. Int J Mol Med 1998, 2:653-659.
6. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
7. Csóka A.B., Frost G.I., Heng H.H., et al. The hyaluronidase gene HYAL-1 maps to chromosome 3p21.2-p21.3 in human and 9F1-F2 in mouse, a conserved candidate tumor suppressor locus. Genomics 1998, 48:63-70.
8. Csoka A.B., Frost G.I., Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol 2001, 20:499-508.
9. Csóka A.B., Frost G.I., Wong T., Stern R. Purification and microsequencing of hyaluronidase isozymes from human urine. FEBS Lett 1997, 417:307-310.
10. Csóka A.B., Scherer S.W., Stern R. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. Genomics 1999, 60:356-361.
11. De Maeyer E., De Maeyer-Guignard J. The growth rate of two transplantable murine tumors, 3LL lung carcinoma and B16F10 melanoma, is influenced by HYAL-1, a locus determining hyaluronidase levels and polymorphism. Int J Cancer 1992, 51:657-660.
12. Dorfman A., Ott M.L., Whitney R. The hyaluronidase inhibitor of human blood. J Biol Chem 1948, 174:621-629.
13. Edelson M.I., Scherer S.W., Tsui L.C., et al. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas. Oncogene 1997, 14:2784-2979.
14. Fiszer-Szafarz B. Demonstration of a new hyaluronidase inhibitor in serum of cancer patients. Proc Soc Exp Biol Med 1968, 129:300-302.
15. Fiszer-Szafarz B., Szafarz D., Vannier P. Polymorphism of hyaluronidase in serum from man, various mouse strains and other vertebrate species revealed by electrophoresis. Biol Cell 1990, 68:95-100.
16. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002, 29:15-18.
17. Formby B., Stern R. Phosphorylation stabilizes alternatively spliced CD44 mRNA transcripts in breast cancer cells. Inhibition by antisense complementary to casein kinase II mRNA. Mol Cell Biochem 1998, 187:23-31.
18. Formby B., Stern R. Lactate-sensitive response elements in genes involved in hyaluronan catabolism. Biochem Biophys Res Commun 2003, 305:203-208.
19. Frost G.I., Csóka A.B., Wong T., Stern R. Purification, cloning, and expression of human plasma hyaluronidase. Biochem Biophys Res Commun 1997, 236:10-15.
20. LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA. Oncogene 2000, 19:870-877.
21. Fujisaki T., Tanaka Y., Fujii K., et al. CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res 1999, 59:4427-4434.
22. Ghatak S., Misra S., Toole B.P. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 2002, 277:38013-38020.
23. Godin D.A., Fitzpatrick P.C., Scandurro A.B., et al. PH-20: a novel tumor marker for laryngeal cancer. Arch Otolaryngol Head Neck Surg 2000, 126:402-404.
24. Haas E. On the mechanism of invasion. I. Anti-invasin, an enzyme in plasma. J Biol Chem 1946, 163:63-88.
25. Jacobson A., Rahmanian M., Rubin K., Heldin P. Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors. Int J Cancer 2002, 102:212-219.
26. Junker N., Latini S., Petersen L.N., Kristjansen P.E. Expression and regulation patterns of hyaluronidases in small cell lung cancer and glioma lines. Oncol Rep 2003, 10:609-616.
27. Kiriluk L.B., Kremen A.J., Glick D. Mucolytic enzyme systems XII. Hyaluronidase in human and animal tumors, and further studies on the serum hyaluronidase inhibitor in human cancer. J Natl Cancer Inst 1950, 10:993-1000.
28. Klocker J., Sabitzer H., Raunik W., Wieser S., Schumer J. Hyaluronidase as additive to induction chemotherapy in advanced squamous cell carcinoma of the head and neck. Cancer Lett 1998, 131:113-115.
29. Kolárová M. Host-tumor relationship XXXIII. Inhibitor of hyaluronidase in blood serum of cancer patients. Neoplasma 1975, 22:435-439.
30. Kovar J.L., Johnson M.A., Volcheck W.M., Chen J., Simpson M.A. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol 2006, 169:1415-1426.
31. Kumar S., West D.C., Ponting J.M., Gattamaneni H.R. Sera of children with renal tumours contain low-molecular-mass hyaluronic acid. Int J Cancer 1989, 44:445-448.
32. Lokeshwar V.B., Cerwinka W.H., Lokeshwar B.L. HYAL-1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion. Cancer Res 2005, 65:2243-2250.
33. Lokeshwar V.B., Lokeshwar B.L., Pham H.T., Block N.L. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res 1996, 56:651-657.
34. Lokeshwar V.B., Obek C., Pham H.T., et al. Urinary hyaluronic acid and hyaluronidase, markers for bladder cancer detection and evaluation of grade. J Urol 2000, 163:348-356.
35. Lokeshwar V.B., Schroeder G.L., Carey R.I., Soloway M.S., Iida N. Regulation of hyaluronidase activity by alternative mRNA splicing. J Biol Chem 2002, 277:33654-33663.
36. Madan A.K., Pang Y., Wilkiemeyer M.B., Yu D., Beech D.J. Increased hyaluronidase expression in more aggressive prostate adenocarcinoma. Oncol Rep 1999, 6:1431-1433.
37. Madan A.K., Yu K., Dhurandhar N., et al. Association of hyaluronidase and breast adenocarcinoma invasiveness. Oncol Rep 1999, 6:607-609.
38. Mateo M., Mollejo M., Villuendas R., et al. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol 1999, 154:1583-1589.
39. Mio K., Stern R. Inhibitors of the hyaluronidases. Matrix Biol 2002, 21:31-37.
40. Mio K., Carrette O., Maibach H.I., Stern R. Evidence that the serum inhibitor of hyaluronidase may be a member of the inter-alpha-inhibitor family. J Biol Chem 2000, 275:32413-32421.
41. Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 15 2006, 69:562-573.
42. Neame S.J., Isacke C.M. Phosphorylation of CD44 in vivo requires both Ser-323 and Ser-325 but does not regulate membrane localization or cytoskeletal interaction in epithelial cells. EMBO J 1992, 11:4733-4738.
43. Novak U., Stylli S.S., Kaye A.H., Lepperdinger G. Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells. Cancer Res 1999, 59:6246-6250.
44. Oh J.J., Boctor B.N., Jimenez C.A., et al. Promoter methylation study of the H37/RBM5 tumor suppressor gene from the 3p21.3 human lung cancer tumor suppressor locus. Hum Genet 2007, 123:55-64.
45. Okamoto I., Tsuiki H., Kenyon L.C., et al. Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am J Pathol 2002, 160:441-447.
46. Pawlowski A., Haberman H.F., Menon I.A. The effects of hyalurodinase upon tumor formation in BALB/c mice painted with 7,12-dimethylbenz-(a)anthracene. Int J Cancer 1979, 23:105-109.
47. Shuster S., Frost G.I., Csoka A.B., Formby B., Stern R. Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int J Cancer 2002, 102:192-197.
48. Simpson M.A. Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice. Am J Pathol 2006, 169:247-257.
49. St Croix B., Man S., Kerbel R.S. Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors. Cancer Lett 1998, 131:35-44.
50. Stern R. Devising a pathway for hyaluronan catabolism: are we there yet?. Glycobiology 2003, 13(12):105R-115R.
51. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 2004, 83:317-325.
52. Stern R. Mammalian hyaluronidases, an update. Glycoforum website http://www.glycoforum.gr.jp.
53. Stern R., Asari A.A., Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 2006, 85:699-715.
54. Stern R., Jedrzejas M. Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev 2006, 106:818-839.
55. Stern R., Shuster S., Neudecker B.A., Formby B. Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Exp Cell Res 2002, 276:24-31.
56. Stern R., Shuster S., Wiley T.S., Formby B. Hyaluronidase can modulate expression of CD44. Exp Cell Res 2001, 266:167-176.
57. Sugahara K.N., Hirata T., Hayasaka H., et al. Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments. J Biol Chem 2006, 281:5861-5868.
58. Sugahara K.N., Murai T., Nishinakamura H., et al. Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem 2003, 278:32259-32265.
59. Warburg O. On the origin of cancer cells. Science 1956, 129:309-314.
60. Warburg O., Posener K., Negelein E. Ueber den Stoffwechsel der Carcinomzelle. Biochem Z 1924, 152:309-344.
61. West D.C., Hampson I.N., Arnold F., Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985, 228:1324-1326.
62. Wong M.L., Tao Q., Fu L., Wong K.Y., et al. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Int J Oncol 2006, 28:767-773.
63. Xu H., Ito T., Tawada A., et al. Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. J Biol Chem 2002, 277:17308-17314.
64. Zabarovsky E.R., Lerman M.I., Minna J.D. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002, 21:6915-6935.